Table 1.

Clinical summary

Variable	Control (n=18)	Treated (n=6)	P Value
Pretreatment B cell counts (cells/μl)	1066.4±637.8	1353.0±1057.9	0.55
B cell counts in peri-transplant period (cells/μl)	0.67±1.30	0.03±0.08	0.06
Anti–non-Gal antibody levels before transplant (MFI)
IgG	7.38±0.65	7.97±1.02	0.32
IgM	13.32±1.16	14.17±2.06	0.50
Onset of proteinuria after transplant (d)
2+ proteinuriaa	1.39±0.61	>12.50±5.54	0.004
3+ proteinuriab	8.25±5.69	19.75±10.87	0.12

Control animals did not receive rituximab in peri-transplant period. Treated animals received rituximab in peri-transplant period to prevent post-transplant proteinuria. The data are shown as mean±SD. MFI, mean fluorescence intensity by FACS

^aEstimated protein concentration is 100 mg/dl.

^bEstimated protein concentration is 500 mg/dl.